Health Catalyst (HCAT) Enterprise Value (2018 - 2026)

Health Catalyst has reported Enterprise Value for 9 years, with the latest figure at -$108.8 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 68.18% year-over-year to -$108.8 million; the trailing twelve-month figure through Mar 2026 stood at -$108.8 million (up 68.18% YoY), and the FY2025 full-year result was -$95.7 million, up 75.58% from the prior year.
• Enterprise Value for Q1 2026 stood at -$108.8 million, down from -$95.7 million in the prior quarter.
• The five-year high for Enterprise Value was -$91.5 million in Q3 2025, with the low at -$425.4 million in Q1 2022.
• Historically, Enterprise Value has averaged -$299.4 million across 5 years, with a median of -$343.8 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value sank 59.67% — and 2025, when it jumped 76.36%.
• Health Catalyst's Enterprise Value stood at -$363.5 million in 2022, then climbed by 12.59% to -$317.7 million in 2023, then dropped by 23.38% to -$392.0 million in 2024, then surged by 75.58% to -$95.7 million in 2025, then retreated by 13.67% to -$108.8 million in 2026.
• The last three Enterprise Value figures came in at -$108.8 million (Q1 2026), -$95.7 million (Q4 2025), and -$91.5 million (Q3 2025), per Business Quant data.